InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: mrmainstreet post# 311559

Tuesday, 11/24/2020 4:18:07 PM

Tuesday, November 24, 2020 4:18:07 PM

Post# of 426504
I think it's very much realistic and it's something the market has not picked up on. Terrapharma tweeted about this last week. Check his twitter.

Just google China and cardiovascular disease. Tons of articles. It's high priority as our western diet has created a lot of heart disease in China.

The best thing is we are working with a local partner in Eddingpharm. They will know how to get the REDUCE-IT label. Their interests are aligned with ours. They want to make money too.

Just the sheer amount of people who live there and as JL always said this is a volume play. Well you have the largest population of people combined with Vascepa's potential.....numbers are staggering.

CVD is a high priority in China.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News